Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough
Moderna, Merck breakthrough could usher in wave of cancer vaccines
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
Merck and Mastercard are seeing real agentic AI results. Both say the plumbing came first.
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Merck’s Top-Seller Cements Status in Hard-to-Treat Breast Cancer
Merck KGaA Sees Semiconductor Business Rebound Amid AI Boom
J&J, Merck, and Bristol Myers Squibb spend billions more on executives and stockholders than on R&D — Senate report points to greed and ‘patent thickets’ as key reasons for high prices
Merck Navigates Chip Geopolitics With ‘China For China’ Strategy
